Processa Pharmaceuticals, Inc. financial data

Symbol
PCSA on Nasdaq
Industry
Pharmaceutical Preparations
Location
7380 Coca Cola Drive, Suite 106, Hanover, Maryland
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Heatwurx, Inc. (to 10/20/2017)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 748 % -6.48%
Debt-to-equity 16.1 % +23.4%
Return On Equity -151 % +35.2%
Return On Assets -130 % +36.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.26M shares -86.7%
Common Stock, Shares, Outstanding 2.87M shares -88.3%
Entity Public Float 10.2M USD -69.8%
Common Stock, Value, Issued 287 USD -88.3%
Weighted Average Number of Shares Outstanding, Basic 2.98M shares +122%
Weighted Average Number of Shares Outstanding, Diluted 2.98M shares +122%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD
Research and Development Expense 2.04M USD +38.5%
General and Administrative Expense 4.78M USD -47.2%
Operating Income (Loss) -10.5M USD +59.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.01M USD -15.2%
Net Income (Loss) Attributable to Parent -10.2M USD +60.2%
Earnings Per Share, Basic -5.13 USD/shares +86.8%
Earnings Per Share, Diluted -5.13 USD/shares +47.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.57M USD -35.8%
Assets, Current 7.48M USD -24.4%
Property, Plant and Equipment, Net 2.28K USD
Operating Lease, Right-of-Use Asset 146K USD -35.8%
Intangible Assets, Net (Excluding Goodwill) 7.47M USD -9.55%
Other Assets, Noncurrent 173K USD -97.8%
Assets 7.6M USD -24.7%
Accounts Payable, Current 953K USD +299%
Accrued Liabilities, Current 505K USD +62.2%
Liabilities, Current 1.55M USD +88.9%
Operating Lease, Liability, Noncurrent 21.8K USD -80%
Liabilities 1.58M USD +69.5%
Retained Earnings (Accumulated Deficit) -81.1M USD -14.4%
Stockholders' Equity Attributable to Parent 6.02M USD -34.2%
Liabilities and Equity 7.6M USD -24.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.05M USD +3.08%
Net Cash Provided by (Used in) Financing Activities 6.26M USD -1.4%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 2.87M shares -88.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.21M USD -0.56%
Deferred Tax Assets, Valuation Allowance 17.6M USD +21.3%
Deferred Tax Assets, Gross 17.6M USD +21.3%
Operating Lease, Liability 109K USD -42.8%
Depreciation 139 USD
Lessee, Operating Lease, Liability, to be Paid 116K USD -44.8%
Operating Lease, Liability, Current 87.5K USD +6.85%
Lessee, Operating Lease, Liability, to be Paid, Year Two 70K USD -24.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 70K USD -24.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.51K USD -64.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 70K USD +4398%
Preferred Stock, Shares Issued 0 shares
Unrecognized Tax Benefits 0 USD
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 197K USD +0.73%